In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

Telemedicine-mediated follow-up for advanced chronic obstructive pulmonary disease potentially improves quality of life and ...

Additionally, one patient who was included in the graph as a VGPR converted to a CR. Taken together, these data show, in fact, that cemsidomide plus dexamethasone has a class-leading anti-myeloma ...

Recent study aimed to explore the impact of verbal communication on the consciousness level, pain, and agitation of ...

Exergaming may positively impact gray matter and white matter in the brain, and these brain changes may be linked to ...

Researchers at the Indiana University School of Medicine, Eskenazi Health, Regenstrief Institute and other partners have ...

Netherlands: Wearing a valgus knee brace can meaningfully reduce walking-related pain in patients with medial compartment ...

Merck has shared positive results from the Phase II IDeate-Lung01 trial (NCT05280470) evaluating ifinatamab deruxtecan (I-DXd) in patients with previously treated extensive-stage small cell lung ...

Large-scale trials presented at the European Society of Cardiology Congress showed that vaccines against influenza and ...

EVERLAST-A Phase 2a trial enrollment ongoing with data expected 2H 2026 MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology ...

Researchers at the Indiana University School of Medicine, Eskenazi Health, Regenstrief Institute and other partners have demonstrated the feasibility of conducting dementia prevention trials among ...

Results from the phase 2 study C-145-03 (NCT03083873) suggest the role of autologous tumor-infiltrating lymphocyte (TIL) ...